Federal Survey Delivers Encouraging Numbers on Youth Substance Use
The Substance Abuse and Mental Health Services Administration released its National Survey on Drug Use and Health on Monday, covering trend data from 2021 to 2025. The findings show measurable progress on several fronts, particularly for young Americans.
Fewer adolescents aged 12 to 17 reported using tobacco, alcohol, marijuana or binge drinking in the previous month. The same age group also recorded declining trends for major depressive episodes, and fewer reported serious thoughts of suicide, making a suicide plan, or attempting suicide.
The report arrived under notable circumstances. Last year, the Trump administration laid off the entire 17-member team responsible for producing the survey. Questions circulated at the time about whether the data would continue to be collected and published. SAMHSA released the report regardless.
The gap that still demands attention
The positive headline numbers coexist with a stubborn treatment gap. According to Robyn Oster, policy director for the Partnership to End Addiction, nearly 45 million people still have substance use disorder. Oster said 'well over 80% of people who needed it did not get substance use treatment in the past year, let alone quality treatment.'
The broader adult population also shows persistent use. The survey found more than half of people over age 12 used an illicit drug, drank alcohol, used tobacco or vaped nicotine in the previous month. That breaks down to 44% who drank alcohol, 16% who used a tobacco product, 10% who vaped nicotine and 16% who used an illicit drug.
Anxiety remains a significant burden on the young. Nearly 20% of adolescents surveyed reported moderate or severe anxiety symptoms in the previous two weeks, compared with about 7% of adults over 18.
'There's still a lot of work to be done,' Oster said.
What the numbers actually tell us
The data carry a straightforward lesson that Washington's bureaucratic class rarely volunteers: outcomes and headcount are not the same variable. A 17-person federal team was eliminated, and the survey still got done. Teen drug and suicide metrics moved in the right direction. That does not resolve the treatment-access problem Oster identifies — 45 million Americans with substance use disorder is a serious number, and an 80%-plus treatment gap is not a talking point, it is a public health failure that predates the current administration by decades.
The honest reading is that leaner government overhead did not cause the youth improvements, but it also did not prevent them. What will actually close the treatment gap is a functioning market for addiction services — one with clear reimbursement rules, fewer regulatory barriers to provider entry, and accountability for outcomes rather than for process. Bureaucratic infrastructure is not a substitute for that. The survey survived the cuts. Now the harder question is whether the treatment system can be reformed to reach the tens of millions the data say are still going without help.
